In both parental and ECC1-ESR1 CRISPR KO endometrial cancer cells, PR levels were progressively elevated in response to increasing concentrations of LBH589, with a corresponding dose-dependent decrease in Myc expression (Fig 2). This evidence concerns the gene MYC and endometrial cancer.